News & Events
Read our recent press releases and follow Vascudyne’s newest advancements
Vascudyne to Supply Vascular Tissues for University of Minnesota Department of Defense-funded Study
The University of Minnesota Twin Cities has received a $3.7M grant from the U.S. Department of Defense (DoD) to develop bioengineered blood vessels that grow with the patient. These vascular tissues will be manufactured by Vascudyne using donor skin cells, which are then removed after the tissue has been developed. The patient’s own cells are expected to repopulate the implanted tissue and allow for blood vessel growth and regeneration as the child grows.
The DoD-funded study will complete pre-clinical work in preparation for human clinical trials and will test Vascudyne’s vascular tissues in lambs, in partnership with Experimental Surgical Services in the University of Minnesota’s Medical School.
The study is led by Professor Robert Tranquillo, Distinguished McKnight University Professor in the Department of Biomedical Engineering and the Department of Chemical Engineering and Materials Science, and Zeeshan Syedain, Ph.D., Senior Research Associate in Professor Tranquillo’s lab and Vascudyne’s Chief Scientific Officer.
Address
Social Media
These are investigational uses that have not been approved by any health authority. Safety and efficacy have not been established and there is no guarantee that pipeline products or investigational uses will receive approval from health authorities.
Copyright 2025 | Vascudyne, Inc.
